Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditionsSeiichi Okabe(Tokyo Medical University), Akihiko Gotoh(Tokyo Medical University)Research SquareNovember 22, 202110.21203/rs.3.rs-1091276/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersActivity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells|Cancer Cell International|2013|21Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells|Oncotarget|2018|9